Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Silencing of Lactotransferrin expression by methylation in prostate cancer progression.
Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez L, Nau M, Ravindranath L, Kim KH, Mohammed A, Chen Y, Ehrich M, Srikantan V, Sesterhenn IA, McLeod D, Vahey M, Petrovics G, Dobi A, Srivastava S. Shaheduzzaman S, et al. Among authors: nau m. Cancer Biol Ther. 2007 Jul;6(7):1088-95. doi: 10.4161/cbt.6.7.4327. Cancer Biol Ther. 2007. PMID: 17568188 Free article.
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome.
Petrovics G, Liu A, Shaheduzzaman S, Furusato B, Sun C, Chen Y, Nau M, Ravindranath L, Chen Y, Dobi A, Srikantan V, Sesterhenn IA, McLeod DG, Vahey M, Moul JW, Srivastava S. Petrovics G, et al. Among authors: nau m. Oncogene. 2005 May 26;24(23):3847-52. doi: 10.1038/sj.onc.1208518. Oncogene. 2005. PMID: 15750627
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
Derosa CA, Furusato B, Shaheduzzaman S, Srikantan V, Wang Z, Chen Y, Seifert M, Ravindranath L, Young D, Nau M, Dobi A, Werner T, McLeod DG, Vahey MT, Sesterhenn IA, Srivastava S, Petrovics G. Derosa CA, et al. Among authors: nau m. Prostate Cancer Prostatic Dis. 2012 Jun;15(2):150-6. doi: 10.1038/pcan.2011.61. Epub 2011 Nov 29. Prostate Cancer Prostatic Dis. 2012. PMID: 22343836
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation.
Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B, Shaheduzzaman S, Tan SH, Vaidyanathan G, Whitman E, Hawksworth DJ, Chen Y, Nau M, Patel V, Vahey M, Gutkind JS, Sreenath T, Petrovics G, Sesterhenn IA, McLeod DG, Srivastava S. Sun C, et al. Among authors: nau m. Oncogene. 2008 Sep 11;27(40):5348-53. doi: 10.1038/onc.2008.183. Epub 2008 Jun 9. Oncogene. 2008. PMID: 18542058 Free PMC article.
Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
Furusato B, Shaheduzzaman S, Petrovics G, Dobi A, Seifert M, Ravindranath L, Nau ME, Werner T, Vahey M, McLeod DG, Srivastava S, Sesterhenn IA. Furusato B, et al. Among authors: nau me. Prostate Cancer Prostatic Dis. 2008;11(2):194-7. doi: 10.1038/sj.pcan.4501007. Epub 2007 Sep 4. Prostate Cancer Prostatic Dis. 2008. PMID: 17768422
144 results